RAD 502

DB17328ExperimentalProtein Based Therapies

RAD 502: Overview.

Also known as
Lutetium-177 labeled humanized monoclonal antibody targeting leucine rich repeat containing 15 (LRRC15) ยท Radiolabelled DUNP19
Code names
RAD-502

Which companies are running trials of RAD 502, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In